KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Cash from Investing Activities (2016 - 2025)

HCA Healthcare (HCA) has disclosed Cash from Investing Activities for 16 consecutive years, with -$1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 2.15% to -$1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.0 billion, a 1.11% decrease, with the full-year FY2025 number at -$5.0 billion, down 1.11% from a year prior.
  • Cash from Investing Activities was -$1.3 billion for Q4 2025 at HCA Healthcare, up from -$1.4 billion in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $640.0 million in Q3 2021 to a low of -$1.7 billion in Q4 2021.
  • A 5-year average of -$1.1 billion and a median of -$1.2 billion in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: surged 220.75% in 2021, then plummeted 185.31% in 2022.
  • HCA Healthcare's Cash from Investing Activities stood at -$1.7 billion in 2021, then surged by 53.73% to -$793.0 million in 2022, then crashed by 101.39% to -$1.6 billion in 2023, then grew by 15.72% to -$1.3 billion in 2024, then grew by 2.15% to -$1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Cash from Investing Activities are -$1.3 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$1.3 billion (Q2 2025).